JP2003169843A - Medicine volatilizing instrument - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a medicine volatilizing instrument in which a medicine can be volatilized from the upper face of a preparation in the case of natural volatilization and forced volatilization and a large quantity of medicines can be efficiently discharged in the air in the case of the forced volatilization. <P>SOLUTION: This instrument is provided with an air blowing vessel 1 having a first and a second air ventilation parts 1b and 1d and equipped with an air blower 2, a medicine container 3 provided in this air blowing vessel 1 and having an opening 3a for volatilization and an air circulation path 3b opened on the upper surface thereof, a preparation 4 stored in this medicine container 3 and containing volatile medicines and a cover body 5 having an air ventilation part 5a and an air current guide plane 5b and mounted on the air blowing vessel 1. When the air blower 2 is stopped, the medicines are volatilized from an upper surface 4a of the preparation 4 and discharged from the air ventilating part 5a into the air and by driving the air blower 2, air hits the air current guide plane 5b, flows toward the opening part 3a for volatilization and hits the upper surface 4a of the preparation 4 so that the medicines can be volatilized. <P>COPYRIGHT: (C)2003,JPO

Description

Detailed Description of the Invention

[0001]

TECHNICAL FIELD The present invention relates to a fragrance, a deodorant,
It is a device that volatilizes volatile chemicals such as aromatic deodorants, disinfectants, insecticides, pest repellents, etc., which is placed in an appropriate place in the room to volatilize naturally, or forced to blow air as necessary. The present invention relates to a drug volatilization instrument that also has the function of volatilizing.

[0002]

2. Description of the Related Art Conventionally, for a drug volatilization device that volatilizes a volatile chemical such as an aromatic, a liquid aromatic such as a liquid aromatic contained in the device is sucked and volatilized through a suction core or There is a natural volatilization type chemical volatilization device that volatilizes the contained gelled aromatic agent from the open part. In addition, a forced volatilization type chemical volatilization device that forcibly volatilizes by placing a breathable drug holder containing a chemical such as an aromatic in a device equipped with a fan and diffusing the drug by the airflow generated by the fan. There is.

[0003]

The former natural volatilization type drug volatilization device has a drawback that it is excellent in durability but not diffusible. Although the latter forced volatilization type drug volatilization device is excellent in diffusibility, it has a drawback that a high-concentration drug is distributed indoors. As mentioned above, two chemical volatilization devices with different volatilization methods have contradictory lengths and have complementary advantages, so both volatilization methods of natural volatilization and forced volatilization are provided and sustainability is maintained. In addition, if a drug volatilization device that can obtain rapid-acting diffusivity is used, it is very convenient that one medicinal volatilization device can be used separately for each merit without separately preparing two types of drug volatilization devices. is there. However, such a drug volatilization device has not been heretofore proposed.

[0004] For example, in the natural volatilization type chemical volatilization device disclosed in Japanese Utility Model Publication No. 55-51471, even if a fan is installed in the inner box to force volatilize, a large amount of chemical cannot be volatilized. Since the flow of air due to is opposite to the release direction of the drug to the outside, a large amount of drug cannot be efficiently released to the atmosphere. In addition, in the case of spontaneous volatilization, the fan hinders the release of the drug.

Further, in the forced volatilization type chemical volatilization device disclosed in Japanese Patent Laid-Open No. 2000-189507, it is possible to adopt the natural volatilization type by stopping the fan. However, this medicine volatilization device sucks air from the inlet of the fragrance storage cassette, circulates the air inside, and sucks the air from the outlet into the air blowing chamber, that is, the fragrance is breathable and distributes the air inside. Then I try to force volatilization. On the other hand, when the fan is stopped to volatilize naturally, the perfume spontaneously volatilizes from the surface portion of the perfume near the inlet and outlet of the perfume storage cassette. For this reason, JP 2000-1
When the chemical volatilization device disclosed in Japanese Patent No. 89507 is used for both forced volatilization and natural volatilization, the method of volatilizing the fragrance (medicine) is volatilization by internal air circulation during forced volatilization, and volatilization from the surface during natural volatilization. The way is different. As described above, if the method of volatilization is different, the properties of the volatilized drug may change depending on the type of drug, which is preferable.

As described above, a large amount of drug cannot be efficiently released to the atmosphere simply by attaching a fan to a conventional volatilization type drug volatilization device, and the conventional forced volatilization type drug volatilization device fan is simply stopped. Then, the method of volatilization of the drug is different between the natural volatilization and the forced volatilization.

The present invention has been made to solve the above-mentioned problems, and its purpose is that the method of volatilizing a drug is the same during natural volatilization and during forced volatilization, and a large amount of drug is It can be efficiently released to the atmosphere, and at any time, it voluntarily volatilizes when it is desired to obtain a high drug effect in the entire room or in a short time while continuously volatilizing volatile chemicals such as fragrances to maintain the drug effect for a long time. It is an object of the present invention to provide a drug volatilization device capable of diffusing a volatile drug such as an aromatic agent with a switching fan.

[0008]

The first aspect of the present invention is to provide an upper surface 1a.
A blower container body 1 having a first ventilation portion 1b and a second ventilation portion 1d on a side surface, and a blower 2 provided in the blower container body 1,
A drug container body 3 provided on the upper surface 1a of the blower container body 1 having a volatilization opening 3a on the upper surface and an air flow passage 3b communicating with the upper surface and the lower surface at approximately the center, and the inside of the drug container body 3 Formulation 4 containing a volatile drug
And a cover body 5 attached to the blower container body 1 and having a ventilation part 5a and an airflow guide surface 5b. The airflow guide surface 5b has a volatilization opening of the medicine container body 3 for the air flowing in from the ventilation part 5a. It is a medicine volatilization instrument which is the shape which flows toward the part 3a.

A second aspect of the invention is that the first ventilation portion 1 is provided on the upper surface 1a.
b, a blower container body 1 having a second ventilation portion 1d on the side surface, a blower 2 provided in the blower container body 1, a volatilization opening portion 3a on the upper surface, and communication between the upper and lower surfaces substantially at the central portion. The upper surface 1 of the blower container body 1 having the air flow passage 3b
A drug container body 3 provided in a, a formulation 4 contained in the drug container body 3 and containing a volatile drug, a cover attached to the blower container body 1 and having a ventilation part 5a and an air flow guide surface 5b. The body 5 is provided, and the air flow guide surface 5b is a drug volatilization device having a shape in which the air flowing in from the air flow passage 3b flows toward the volatilization opening 3a of the drug container body 3.

A third aspect of the invention is a drug volatilization instrument according to the first or second aspect of the invention, in which the air flow passage 3b can be opened and closed by the cover body 5.

[0011]

[Operation] According to the first invention, by driving the blower 2 to suck air from the first ventilation portion 1b, air is sucked from the ventilation portion 5a of the cover body 5, and the air is guided by the airflow guide surface 5b. And flows toward the volatilization opening 3a of the medicine container 3. Therefore, air is applied to almost the entire upper surface 4a of the preparation 4 and a large amount of the drug is vaporized. This volatilized chemical passes through the air flow passage 3b and the first ventilation portion 1b together with the air to the second
It is released to the atmosphere from the ventilation part 1d. Therefore, a large amount of drug can be efficiently released to the atmosphere during forced volatilization.

When the blower 2 is stopped and volatilized spontaneously, the drug volatilized from the upper surface 4a of the preparation 4 is covered by the cover body 5.
It is released to the atmosphere from the ventilation part 5a. Therefore, the drug volatilizes from the upper surface 4a of the preparation 4 during forced volatilization and natural volatilization, and the method of volatilizing the drug is the same during forced volatilization and during natural volatilization.

According to the second aspect of the invention, the blower 2 is driven to suck air from the second ventilation part 1d and discharge it from the first ventilation part 1b to the air flow passage 3b, so that the air is guided to the air flow guide surface 5b. And flows toward the volatilization opening 3a of the medicine container 3. Therefore, air is applied to almost the entire upper surface 4a of the preparation 4 and a large amount of the drug is vaporized. The volatilized drug is released into the air from the ventilation part 5a together with the air, so that a large amount of the drug can be efficiently released into the air during forced volatilization.

Moreover, since the volatilized chemicals do not pass through the blower 2, almost all the volatilized chemicals can be released to the atmosphere, and the inside of the blower 2 is not contaminated with the chemicals.

When the blower 2 is stopped and volatilized spontaneously, the drug volatilized from the upper surface 4a of the preparation 4 is covered by the cover body 5.
It is released to the atmosphere from the ventilation part 5a. Therefore, the drug volatilizes from the upper surface 4a of the preparation 4 during forced volatilization and natural volatilization, and the method of volatilizing the drug is the same during forced volatilization and during natural volatilization.

According to the third aspect of the invention, since the air flow passage 3b can be closed by the cover body 5 during natural volatilization, the naturally volatilized drug can be released to the atmosphere only from the ventilation part 5a of the cover body 5.

[0017]

BEST MODE FOR CARRYING OUT THE INVENTION As shown in FIG.
A blower 2 provided in the blower container body 1, a drug container body 3 provided on the upper surface 1a of the blower container body 1, a preparation 4 contained in the drug container body 3, and the blower container body 1 A cover 5 which is detachably provided on the upper part and covers the drug container body 1 forms a drug volatilization device. The blower container body 1
Has a first ventilation portion 1b on the upper surface 1a, a cover body attachment portion 1c on the upper portion, and a second ventilation portion 1d on the side surface. The blower 2 includes a fan 2a and an electric motor 2 for driving the fan 2a.
b. The upper surface of the drug container body 3 is almost entirely opened and has a volatilization opening 3a. An air flow passage 3b which is continuous with the upper surface and the lower surface is provided at substantially the center of the medicine container body 3. The formulation 4 contains a volatile drug, and its upper surface 4a is exposed to the outside from the volatile opening 3a of the drug container body 3.

The cover body 5 has a ventilation part 5a and an air flow guide surface 5b, and the air flow guide surface 5b is the drug container body 3.
Facing the upper surface of. In the air flow guide surface 5b, the air flowing in from the ventilation portion 5a allows the volatilization opening 3 of the medicine container 3
It has a shape that flows intensively toward a (the upper surface 4a of the formulation 4).

Because of this, when the blower 2 is driven with the cover body 5 attached as shown in FIG. 1 to suck in air from the first ventilation portion 1b, air is sucked in from the ventilation portion 5a and is sucked in. The air hits the airflow guide surface 5b as shown by the arrow a and flows intensively toward the upper surface 4a of the preparation 4. Therefore, the air is uniformly blown onto almost the entire upper surface 4a of the preparation 4, and a large amount of the drug is volatilized from the substantially entire upper surface 4a. This large amount of medicine passes through the air flow passage 3b, the first ventilation portion 1b, and the second ventilation portion 1d together with the air.
Released into the atmosphere. Therefore, a large amount of drug can be efficiently released to the atmosphere during forced volatilization.

When the blower 2 is stopped and volatilized spontaneously, the drug spontaneously volatilizes from the surface 4a of the preparation 4 and the drug is released from the ventilation part 5a of the cover body 5 to the atmosphere. Thus, the drug volatilizes from the surface 4a of the preparation 4 during forced volatilization and natural volatilization, and the method of volatilizing the drug is the same.

During the natural volatilization described above, the volatilized drug may be released from the first ventilation part 1b to the atmosphere from the second ventilation part 1d through the air flow passage 3b of the drug container body 3, but the amount thereof is small. Is.

As shown in FIG. 2, by removing the cover body 5 and directly opening the volatilization opening 3a of the drug container body 3 to the atmosphere, it is possible to prevent natural volatilization of the drug from being released to the atmosphere. There is no such member. Therefore, the chemical can be efficiently released to the atmosphere during spontaneous evaporation.

Next, an example of the concrete shape of each member is shown in FIGS.
It will be described based on. The blower container body 1 includes a top plate 10
The peripheral plate 11, the lower plate 12, and the partition plate 13 have an upper chamber 14a and a lower chamber 14b and have a circular cross section. A male screw 15 is formed near the top of the peripheral plate 11 to serve as the cover body mounting portion 1c. A circular hole 16 is formed in the central portion of the upper surface plate 10 to serve as the first ventilation portion 1b.
A plurality of slit-shaped openings 17 are formed in the peripheral surface plate 11, and the openings 17 open in the upper chamber 14a,
It is used as the ventilation part 1d. The blower 2 is provided in the upper chamber 14a. A battery 18 is housed in the lower chamber 14b, and the battery 18 drives the electric motor 2b. The electric motor 2b may be driven by a commercial power source.

The medicine container 3 has a ring-shaped projection 21 integrally formed on the lower surface of a doughnut-shaped container 20 having an open upper surface. The ring-shaped protrusion 21 is formed in the hole 1 of the top plate 10.
It can be attached by fitting it to 6.

The cover body 5 includes a peripheral plate 30 and an upper plate 31.
The bottom surface is open, and a plurality of holes 32 are formed in the peripheral surface plate 30 at intervals in the circumferential direction to form the ventilation portion 5a. Each of the holes 32 is directed obliquely upward so that the air flows through the top plate 3.
It is made easy to flow toward the lower surface of 1. A female screw 33 is formed on the lower inner circumferential surface of the peripheral plate 30, and the female screw 33 is screwed onto the male screw 15 to attach the cover body 5 to the blower container body 3. The lower surface of the upper surface plate 31 has a shape in which the central portion protrudes and the outer peripheral portion is smoothly recessed to form the airflow guide surface 5a.

As described above, the air flow passage 3b is openable and closable in order to prevent a small amount of the chemicals volatilized during natural volatilization from being discharged from the second ventilation part 1d to the atmosphere. For example, the cover body 5 is attached to the blower container body 1 so as to be vertically movable,
The air flow passage 3b is opened by moving the cover body 5 upward, and the air flow passage 3b is closed by moving it downward. Specifically, as shown in FIG. 4, an opening / closing portion 34 that is fitted to the upper portion of the air flow passage 3b is provided at approximately the center of the upper surface plate 31 of the cover body 5.

As shown by the solid line in FIG. 4, the cover body 5 is moved downward, for example, the cover body 5 is rotated in one direction to rotate the female screw 3
By tightening 3 onto the male screw 15 and moving it downward, the opening / closing part 34 is fitted and closed on the upper part of the air flow passage 3b.

As shown by the phantom line in FIG. 4, the cover body 5 is moved upward, for example, by rotating the cover body 5 in the other direction to loosen the female screw 33 with respect to the male screw 15 and move it upward to open and close. The portion 34 is separated from the upper portion of the air flow passage 3b and opened.

As shown in FIG. 5, the inner peripheral portion (the portion forming the air flow passage 3b) of the drug container body 3 is projected above the outer peripheral portion, and the lower surface of the upper plate 31 of the cover body 5 at substantially the central portion. 35 is a shape that is in contact with the upper end surface 36 of the inner peripheral portion, for example, a flat surface. Also in this case, when the cover body 5 is set to the lower position shown by the solid line, the lower surface 35 of the upper surface plate 31 of the cover body 5 contacts the upper end surface 36 to close the air flow passage 3b. The lower surface 3 with the cover body 5 as the upper position shown by a virtual line
The air flow passage 3b is opened by separating 5 from the upper end surface 36.

As shown in FIGS. 6 and 7, the cover body 5 is rotatably attached to the blower container body 1. For example, without providing the male screw 15 and the female screw 33 described above, the flange 19 is integrally provided near the upper portion of the peripheral surface plate 11, and the peripheral surface plate 30 of the cover body 5 is provided.
The lower end surface of the is brought into contact with the flange 19 to be rotatable. A cylindrical body 37 is integrally provided at approximately the center of the upper surface plate 31 of the cover body 5, and the cylindrical body 37 is provided around the upper portion 38 of the inner peripheral portion (the portion forming the air flow passage 3b) of the drug container body 3. To fit. The cylindrical body 37 and the upper portion 38 are provided with notches 37a, 3
8a are formed respectively, and when the cylindrical body 37 rotates together with the cover body 5 by a predetermined angle, the cutout portions 37a and 38a are aligned to open the air flow passage 3b, or the cutout portion 37a of the cylindrical body 37 becomes the remaining portion of the upper portion 38. At the same time, the cutout portion 38a of the upper portion 38 contacts the remaining portion of the tubular body 37 to close the air flow passage 3b.

The notches 37a and 38a may be a plurality of holes. That is, the air flow passage 3b may be opened and closed by rotating the cover body 5 by a predetermined angle.

As shown in FIG. 8, the air flow guide surface 5b has a shape in which the air hitting the substantially central portion flows downward, that is, the air blown from the air flow passage 3b causes the volatilization opening 3a of the drug container body 3 to flow. It may have a shape that flows intensively toward. In this case, the blower 2 is driven to drive the second ventilation section 1
Air is sucked in from the d, and the air flow passage 3 from the first ventilation portion 1b.
Discharge to b. The discharged air is the airflow guide surface 5b.
Then, as shown by the arrow b, it flows intensively toward the volatilization opening 3a of the drug container body 3 and air is applied to almost the entire upper surface 4a of the preparation 4 to volatilize a large amount of drug. A large amount of the chemical is released to the atmosphere from the ventilation part 5a together with the air.

In this case, since the volatilized chemicals do not pass through the blower 2, the total amount of the volatilized chemicals can be released to the atmosphere and the fan 2a is not contaminated with the chemicals.

Also in this embodiment, the cover body 5 may be moved up and down to open and close the air flow passage 3b in the same manner as described above.

The attachment of the medicine container body 3 to the blower container body 1 is not limited to the above. For example, as shown in FIG. 9, a plurality of projecting pieces 22 are provided on the lower surface of the container 20 and the upper plate 1
0 is formed with an insertion recess 23, and the projection 22 is inserted into the insertion recess 2
The container 20 may be attached by fitting the container 20 into the container 3. As shown in FIG. 10, a plurality of pins 24 are provided on the lower surface of the container 20 and a plurality of holes 25 are formed in the upper surface plate 10.
The container 20 may be attached by fitting into.

In each of the above embodiments, the shape of the blower container 1, the medicine container 3 and the cover 5 is not particularly limited and can be freely designed such as a circle, a quadrangle, a polygon or a rhombus. However, the blower container body 1 needs to have a shape in which the installation state is stable. Further, as materials for the blower container body 1, the drug container body 3, and the cover body 5, synthetic resin, ceramics,
Known materials such as metal, paper and wood can be used.

In each of the above-described embodiments, the cover body 5
It is desirable to set the size, shape, forming position, forming number, etc. of the ventilation part 5a according to the type of the volatile drug used. For example, it is preferable to design the air flow rate (air inflow or air release of the volatilized drug-containing air) flowing in and out of the ventilation part 5a to be uniform over the entire circumference without being offset to a part such as one surface of the drug container body 3. . Due to this design, there is no variation in the volatilization of the drug from the drug product. Further, the formation position of the ventilation portion 5a is a side surface of the drug container body 3, preferably a side surface located below the surface of the volatilization opening 3a.

The volatile agents used in the present invention include pest control agents (insecticides, pest repellents, pest growth inhibitors, etc.), aroma and deodorants (fragrances, herbs, deodorants, etc.), Antibacterial and antifungal agents (bactericidal agents, antibacterial agents, antifungal agents, etc.)
Various kinds of chemicals that are volatilized in nature and used for the above purposes can be used alone or in combination of two or more depending on the purpose. For example, when used for the purpose of insecticidal, pyrethroid insecticides, carbamate insecticides, organophosphorus insecticides and the like can be mentioned. Generally, pyrethroid insecticides are preferably used because of their high safety, and the empentrin; 1 -Ethynyl-2-methyl-2-pentenyl d1
-Cis / trans-3- (2,2-dimethylvinyl)-
2,2-Dimethyl-1-cyclopropanecarboxylate, Terraresulin; d1-3-allyl-2-methyl-4
-Oxo-2-cyclopentenyl-d1-cis / trans-2,2,3,3-tetramethyl-cyclopropanecarboxylate, transfluthrin; d-trans-
2,3,5,6-tetrafluorobenzyl-3- (2,2
2-dichlorovinyl) -2,2-dimethyl-1-cyclopropanecarboxylate, flamethrin; 5-propargyl-2-furylmethyl d-cis / trans-chrysanthemate, 1-ethynyl-2-methyl-2-pentenyl. Cis / trans-2,2,3,3-tetramethyl-1
-Cyclopropanecarboxylate, 2,3,5,6-
Tetrafluoro-4-methoxymethylbenzyl-3-
Examples include (1-propenyl) -2,2-dimethylcyclopropanecarboxylate. Further, as a pest repellent, N, N-diethyl-m-toluamide, dimethyl phthalate, 2-ethyl-1,3-hexanediol, p
-Mentene-3,8-diol, camphor and the like can be exemplified by pest growth inhibitors such as methoprene. As the fragrance / deodorant, various natural and artificial flavors can be used as flavors, for example, animal or plant natural flavors, or hydrocarbons, alcohols, phenols, aldehydes, ketones, lactones, oxides, esters. Examples of the deodorant such as artificial flavors such as benzyl acetate, amylcinnamic aldehyde, citral, methyl benzoate, ethyl benzoate, bornyl acetate, ethyl phenylacetate, etc., and dried plants such as herbs and camphor trees. Examples of the antibacterial / antifungal agent include o-phenylphenol, isopropylmethylphenol, 2-chloro-4-phenylphenol, thymol, α-promo-cinnamic aldehyde and the like. Furthermore, eucalyptus oil, lemongrass oil, lemon oil, hinokitiol, citronella oil, peppermint oil, orange flower oil, geranium oil, spearmint oil, butternut oil, which shows effects such as insect repellent or sterilization and deodorization,
Examples thereof include plant essential oils such as cinnamon leaf oil, and extractive active ingredients thereof.

The formulation to be used in the present invention may contain a large amount of a volatile drug as a form and be easy to handle.
For example, gel, gel, granules, powder, mat, cotton, fiber, etc. are exemplified. The material of the formulation may be one that releases the volatile drug contained in nature, for example, porous inorganic substances and organic substances, pulp materials,
Examples include gelling materials and synthetic resins. As a fan for the blower, a sirocco fan is preferable, but an axial fan,
A propeller fan can also be used.

[0040]

According to the invention of claim 1, the blower 2
Is driven to draw in air from the first ventilation part 1b, so that air is sucked in from the ventilation part 5a of the cover body 5, the air hits the airflow guide surface 5b and enters the volatilization opening 3a of the drug container body 3. It flows toward. Therefore, air is applied to almost the entire upper surface 4a of the preparation 4 and a large amount of the drug is vaporized. This volatilized medicine is air flow path 3b, the 1st ventilation part 1b with air.
Through the second ventilation part 1d to the atmosphere. Therefore, a large amount of drug can be efficiently released to the atmosphere during forced volatilization.

When the blower 2 is stopped and volatilized naturally,
The drug volatilized from the upper surface 4a of the formulation 4 is released to the atmosphere from the ventilation part 5a of the cover body 5. Therefore, the drug volatilizes from the upper surface 4a of the preparation 4 during forced volatilization and natural volatilization, and the method of volatilizing the drug is the same during forced volatilization and during natural volatilization.

According to the invention of claim 2, the cover body 5
The air blower 2 is driven with the attached air to suck air from the second ventilation part 1d and discharge it from the first ventilation part 1b to the air flow passage 3b, so that the air hits the airflow guide surface 5b and the medicine container body 3 toward the volatilization opening 3a. Therefore, air is applied to almost the entire upper surface 4a of the preparation 4 and a large amount of the drug is vaporized. The volatilized drug is released into the air from the ventilation part 5a together with the air, so that a large amount of the drug can be efficiently released into the air during forced volatilization.

Moreover, since the volatilized chemicals do not pass through the blower 2, almost all the volatilized chemicals can be released to the atmosphere, and the inside of the blower 2 is not contaminated with the chemicals.

When the blower 2 is stopped and volatilized naturally,
The drug volatilized from the upper surface 4a of the formulation 4 is released to the atmosphere from the ventilation part 5a of the cover body 5. Therefore, the drug volatilizes from the upper surface 4a of the preparation 4 during forced volatilization and natural volatilization, and the method of volatilizing the drug is the same during forced volatilization and during natural volatilization.

According to the third aspect of the present invention, since the air flow passage 3b can be closed by the cover body 5 during natural volatilization, the naturally volatilized drug can be released to the atmosphere only from the ventilation part 5a of the cover body 5.

[Brief description of drawings]

FIG. 1 is a cross-sectional view in a forced volatilization state.

FIG. 2 is a cross-sectional view showing a state of natural volatilization.

FIG. 3 is a perspective view of a blower container body, a medicine container body, and a cover body.

FIG. 4 is a perspective view showing a first embodiment for opening and closing an air flow passage.

FIG. 5 is a perspective view showing a second embodiment for opening and closing an air flow passage.

FIG. 6 is a perspective view showing a third embodiment for opening and closing an air flow passage.

FIG. 7 is a perspective view of an upper portion of a cylindrical body.

FIG. 8 is a cross-sectional view showing a second embodiment of an airflow guide surface of a cover body.

FIG. 9 is a perspective view showing a second embodiment of a portion to which a medicine container body is attached.

FIG. 10 is a perspective view showing a third embodiment of a portion to which a medicine container body is attached.

[Explanation of symbols]

1 ... Blower container body, 1a ... Upper surface, 1b ... 1st ventilation part, 1d
... 2nd ventilation part, 2 ... air blower, 3 ... drug container body, 3a ... volatilization opening part, 3b ... air flow passage, 4 ... formulation, 4a ... top surface, 5 ... cover body, 5a ... ventilation part, 5b ... air flow Guide surface.

   ─────────────────────────────────────────────────── ─── Continued front page    (72) Inventor Yuro Shiro             1-18 Rakuen 1-chome, Saiki-ku, Hiroshima-shi, Hiroshima (72) Inventor Koji Takei             4-31-3 Iguchi, Nishi-ku, Hiroshima City, Hiroshima Prefecture F term (reference) 2B121 CA02 CA16 CA20 CA21 CA32                       CA43 CA44 CA61 EA01 FA08                 4C002 AA03 AA06 BB03 DD03 DD05                       EE01 FF01 HH01 KK04

Claims (3)

[Claims] 1. A first ventilation part 1b on the upper surface 1a and a second ventilation part on the side surface.
A blower container body 1 having a ventilation part 1d, a blower 2 provided in the blower container body 1, an volatilization opening 3a on the upper surface, and an air flow passage 3b communicating with the upper surface and the lower surface at a substantially central portion. A drug container body 3 which is provided on the upper surface 1a of the blower container body 1, a formulation 4 which is contained in the drug container body 3 and contains a volatile drug, and which is attached to the blower container body 1 and has a ventilation part. The medicine volatilization device is provided with a cover body 5 having 5a and an airflow guide surface 5b, and the airflow guide surface 5b has a shape in which the air flowing in from the ventilation portion 5a flows toward the volatilization opening 3a of the medicine container body 3. 2. A first ventilation part 1b on the upper surface 1a and a second ventilation part on the side surface.
A blower container body 1 having a ventilation part 1d, a blower 2 provided in the blower container body 1, an volatilization opening 3a on the upper surface, and an air flow passage 3b communicating with the upper surface and the lower surface at a substantially central portion. A drug container body 3 which is provided on the upper surface 1a of the blower container body 1, a formulation 4 which is contained in the drug container body 3 and contains a volatile drug, and which is attached to the blower container body 1 and has a ventilation part. A drug volatilization device is provided with a cover body 5 having an air flow guide surface 5b and an air flow guide surface 5b. The air flow guide surface 5b has a shape in which air flowing from the air flow passage 3b flows toward the volatilization opening 3a of the drug container body 3. 3. The drug volatilization instrument according to claim 1, wherein the air flow passage 3b can be opened and closed by the cover body 5.